In type 2 diabetic patient with coronary artery disease, infusion of GLP-1 increased flow-mediated vasodilatation in the brachial artery, affirming the NO-dependent mechanism of GLP-1 in the vascular system [81]. Here, GLP1R is linked to coronary artery disorder.